Vitaccess strengthens leadership team with appointment of Matt Reaney as Chief Scientific Officer
London, UK – 13 April 2026, Vitaccess, a leader in generating science-driven real-world evidence, today announced the appointment of Matt Reaney as Chief Scientific Officer (CSO), expanding the company’s executive team. Matt brings over two decades of experience...
Vitaccess announces first-of-its-kind CIDP Registry and first patient enrolled in landmark patient-centered evidence platform
Boston, MA, USA and London, UK – 8 April 2026, Vitaccess, a leader in generating science-driven real-world evidence, announces the launch of the Vitaccess Real CIDP Registry, a first-of-its-kind patient-centered registry in chronic inflammatory demyelinating...
Vitaccess and Myasthenia Gravis Foundation of America form strategic partnership to advance generation of real-world evidence in MG
Boston, MA, USA and Oxford, UK – 12 February 2026. Vitaccess, a leader in generating science-driven real-world evidence, has entered into an exclusive partnership with the Myasthenia Gravis Foundation of America (MGFA), making the MGFA the official collaborator for...
Envision Pharma Group and Vitaccess create a global partnership
Envision Pharma Group and Vitaccess create a global partnership to power evidence generation for the biopharmaceutical industry Move combines Envision’s global leadership position in medical affairs communications with Vitaccess’ award-winning capabilities in...